ClinicalTrials.Veeva

Menu

Brief Admission for Adolescents Who Self-harm

R

Region Skane

Status

Completed

Conditions

Suicide, Attempted
Suicidal
Non-Suicidal Self Injury
Self-Harm, Deliberate

Treatments

Other: Semi-structured interviews

Study type

Observational

Funder types

Other

Identifiers

NCT04962373
2020-01840

Details and patient eligibility

About

There is still no consensus on how to manage suicidal behavior in youth with recurrent self-harm at times when the risk for suicide is imminent (1). Brief Admission (BA) has evolved as a promising crisis intervention for adults with self-harm (2). The characteristics of BA is different from other types of admission, being focused on prevention through increased autonomy and self-care, based on structured and voluntary brief self-referrals to hospital (3). As a result of a randomized controlled trial, BA is since January 2019, continuously offered to adults with self-harm at risk for suicide in Skåne (4). Parallel to this clinical trial, the method has been adapted to work in a psychiatric setting for adolescents. At present 24 adolescents have access to the method in Skåne. Clinical experiences from staff are promising, however, the lived experiences have not been collected in a standardized way.

The aim of the present study is to gather information on how BA in its present, standardized form works for adolescents, their loved ones and staff working at the ward providing BA. This will be done through semi-structured interviews with:

  1. Adolescents using BA and their loved ones
  2. Staff working at the ward providing BA. Data will be analyzed with qualitative analysis (5, 6). The ultimate aim is to use these results to optimize the current standardized version of BA for adolescents in order to test in a randomized clinical trial.

Enrollment

59 patients

Sex

All

Ages

13 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Sample 1:

Inclusion Criteria:

  • Adolescents with an active BA contract
  • At least 13 years of age.
  • Able to consent to study participation through written and oral information.
  • Consent from caregivers
  • Given consent to participate

Exclusion Criteria:

  • Below the age of 13.

Sample 2:

Inclusion Criteria:

  • Parents to adolescents with an active BA contract
  • At least 18 years of age.
  • Able to consent to study participation through written and oral information.
  • Given consent to participate

Exclusion Criteria:

  • None

Sample 3:

Inclusion Criteria:

  • Staff working with adolescents with an active BA contract
  • At least 18 years of age.
  • Able to consent to study participation through written and oral information.
  • Given consent to participate

Exclusion Criteria:

  • None

Trial design

59 participants in 3 patient groups

Adolescents
Description:
Adolescents with a contract for Brief admission by self-referral
Treatment:
Other: Semi-structured interviews
Parents
Description:
Parents to adolescents with a contract for Brief admission by self-referral
Treatment:
Other: Semi-structured interviews
Staff
Description:
Health care providers who work with adolescents with a contract for Brief admission by self-referral
Treatment:
Other: Semi-structured interviews

Trial contacts and locations

1

Loading...

Central trial contact

Sofie Westling, MD PhD; Kajsa Landgren, RN PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems